Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK

PURPOSE: Our objective was to estimate the economic outcomes of using mirabegron versus antimuscarinics in the treatment of patients with overactive bladder (OAB) from a societal perspective in the UK. MATERIALS AND METHODS: A Markov model was developed using Microsoft Excel(®). The time horizon and...

Descripción completa

Detalles Bibliográficos
Autores principales: Nazir, Jameel, Berling, Malin, McCrea, Charles, Fatoye, Francis, Bowditch, Sally, Hakimi, Zalmai, Wagg, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689035/
https://www.ncbi.nlm.nih.gov/pubmed/29442303
http://dx.doi.org/10.1007/s41669-017-0011-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689035/
https://www.ncbi.nlm.nih.gov/pubmed/29442303
http://dx.doi.org/10.1007/s41669-017-0011-x

Ejemplares similares